A publicly listed global leader in peptide biotechnology headquartered in South Korea, Caregen has focused on advancing human health through peptide innovation since 2001, developing more than 1,800 proprietary peptides and securing more than 860 global patents across pharmaceuticals, nutraceuticals, medical aesthetics and cosmeceuticals, guided by a commitment to scientific integrity and clinically validated peptide innovation.

Chưa có bình luận nào.
Để lại đánh giá & nhận xét